What happens when you take phenytoin with st. john's wort?
Phenytoin (brand names Dilantin and Phenytek) is an old, narrow-therapeutic-index anticonvulsant. "Narrow therapeutic index" means there is a small gap between a level that controls seizures and a level that causes side effects like nystagmus, ataxia, and confusion. The drug is metabolized primarily by the liver enzymes CYP2C9 and CYP2C19, with smaller contributions from other CYP pathways.
St. John's Wort (Hypericum perforatum) is one of the most aggressive natural inducers of drug metabolism known. Its active constituent hyperforin activates the pregnane X receptor (PXR), which then ramps up production of CYP3A4, CYP2C9, CYP2C19, and the efflux pump P-glycoprotein. The effect is dose-dependent and tied to the hyperforin content of the specific extract.
Put those facts together and the result is predictable: take phenytoin and add St. John's Wort, and your liver clears phenytoin faster than expected. Plasma levels drop. If they drop far enough, breakthrough seizures become possible. Multiple national drug safety agencies (including New Zealand's Medsafe and the UK MHRA) explicitly flag this combination as one to avoid.
Why is this important?
Three things make this interaction high-stakes.
First, phenytoin has saturable, non-linear kinetics. Below saturation, small dose increases produce small level increases; near saturation, small dose changes can produce big level swings in either direction. That makes any external influence on metabolism harder to manage.
Second, the consequence of underdosing phenytoin in a person with epilepsy is not a missed therapeutic target. It is a seizure, with all the safety risks that brings: head injuries, falls, motor vehicle crashes, drowning, and rarely SUDEP (sudden unexpected death in epilepsy). Fatal breakthrough seizures have been documented in case reports where patients self-medicated with herbal supplements alongside their anticonvulsants.
Third, the interaction is bidirectional in time. Starting St. John's Wort lowers phenytoin levels over 1-2 weeks. Stopping St. John's Wort then lets phenytoin levels rise again as the induced enzymes regress to baseline. If the prescriber compensated by increasing the phenytoin dose during the St. John's Wort phase, the patient can find themselves toxic after the herb is discontinued. So the safe move is not to stop St. John's Wort cold turkey and assume things will balance out.
Finally, St. John's Wort is sold over the counter for mild to moderate depression, anxiety, and sleep, and many users assume "natural" means "safe with my prescriptions." It does not. The herb-drug interaction profile of St. John's Wort is more clinically significant than most prescription drug-drug interactions.
What should you do?
If you take phenytoin, do not start St. John's Wort. This is one of the clearest "avoid" combinations in herbal-pharmaceutical interaction tables.
If you are already taking both and need to discontinue St. John's Wort, do it under medical supervision. Ask your prescriber about checking a baseline phenytoin level (free and total), then rechecking 1-2 weeks after stopping the herb. A pre-emptive small dose reduction may be appropriate, but the right move depends on your current level and clinical picture.
If you have epilepsy and want to address depression, talk to your prescriber about evidence-based options. Several SSRIs and SNRIs can be used safely alongside phenytoin with monitoring, though dose adjustments may be needed. Your neurologist and primary care provider can coordinate.
If you have already had a breakthrough seizure while on the combination, treat it as an emergency-grade safety event: do not drive, get a phenytoin level checked, and have a structured plan for stopping St. John's Wort rather than just stopping it on your own.
Which specific products are affected?
On the medication side:
- Dilantin (capsules, chewable tabs, oral suspension)
- Phenytek (extended-release capsules)
- Generic phenytoin sodium capsules and tablets
- IV phenytoin used in hospital settings
The related prodrug fosphenytoin (Cerebyx) is converted to phenytoin in the body and is affected by the same interaction.
On the supplement side, the concern applies to essentially all St. John's Wort products with meaningful hyperforin content:
- Standardized St. John's Wort capsules and tablets (300-900 mg/day, often standardized to 0.3% hypericin or specified hyperforin content)
- St. John's Wort teas and tinctures
- Combination "mood support" or "calm" herbal blends that include Hypericum perforatum
Low-hyperforin extracts have been marketed as having fewer interactions, but the interaction risk with phenytoin is high enough that no commercial St. John's Wort product can be considered safe to combine.
The bottom line
St. John's Wort and phenytoin is a combination to avoid. The herb speeds up the enzymes that clear phenytoin, drops plasma levels, and can trigger breakthrough seizures, while stopping the herb later can swing levels into the toxic range. If you take phenytoin and feel depressed, talk to your prescriber about safer treatment options rather than reaching for an herbal product that has more clinically significant interactions than most prescription drugs.